{
    "clinical_study": {
        "@rank": "38565", 
        "arm_group": {
            "arm_group_label": "experimental pain induction", 
            "arm_group_type": "Experimental", 
            "description": "application of a pre-fixed pressure (160 kPa) on the forearm"
        }, 
        "brief_summary": {
            "textblock": "The principal study aims at evaluating the efficiency of rTMS maintenance sessions on the\n      clinical effect of a rTMS cure in fibromyalgic subjects. This complementary study consists\n      in the evaluation of the experimental sensitivity to mechanical pain (pressure application\n      on the forearm) of subjects presenting fibromyalgia before and after rTMS treatment (21\n      days), and to put the results in relation to the clinical improvement and the psychometric\n      evaluations (depression,fibromyalgia impact questionnaire, catastrophism)."
        }, 
        "brief_title": "Pain Sensitivity of Subjects With Fibromyalgia Before and After Repetitive Transcranial Magnetic Stimulation Treatment", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Fibromyalgia", 
        "condition_browse": {
            "mesh_term": [
                "Fibromyalgia", 
                "Myofascial Pain Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Inclusion Criteria:\n\n        presence of the criteria from the American College of Rheumatology (2010)for fibromyalgia\n        diagnosis, painful state for more than six months, visual analogic scale evaluation > or =\n        5, age between 18 and 70, no modification in therapeutic treatment one month before and\n        during the protocol presence of actual or prior antalgic chronic treatment : pregabalin,\n        duloxetine, milnacipran, gabapentin, venlafaxine, laroxyl, grade 1 or 2 antalgic residence\n        in Limoges or the periphery, or the ability to come to the hospital for the treatment\n\n        Exclusion Criteria:\n\n        presence of non stabilized psychiatric comorbidity (personality trouble, addiction,\n        suicide attempt, non controlled affective trouble), active epilepsy, previous cerebral\n        traumatism, or cerebral surgery, intra-cranial hyper tension, pacemaker, metallic pieces\n        in the brain, cochlear ocular implant, or any metallic material contra indicating magnetic\n        resonance imaging.\n\n        clozapine, bupropion, methadon, theophyllin, or other non chemical antalgic technic\n        established during the previous month(kinesitherapy, relaxation, hypnosis...), pregnancy,\n        or administrative and judiciary protection, absence of health insurance.\n\n        known latex allergy, peripheral neuropathy, nerve lesion or dermatosis at the upper\n        extremities, muscular lesion or pathology at the upper members, use of illicit drugs 48\n        hours before experimental pain test, use of antalgic or analgesic drug aiming at a\n        punctual treatment during the prior 24 hours."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01992822", 
            "org_study_id": "2013-A01508-37"
        }, 
        "intervention": {
            "arm_group_label": "experimental pain induction", 
            "description": "application of a pre-fixed pressure (160 kPa) on the forearm.", 
            "intervention_name": "experimental pain induction", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "rTMS", 
            "fibromyalgia", 
            "experimental pain"
        ], 
        "lastchanged_date": "May 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Limoges", 
                    "country": "France", 
                    "zip": "87000"
                }, 
                "name": "Centre Hospitalier esquirol"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Experimental Pain Sensitivity of Subjects With Fibromyalgia Before and After rTMS Treatment in Relation to the Clinical Improvement", 
        "overall_contact": {
            "email": "murielle.girard@ch-esquirol-limoges.fr", 
            "last_name": "Murielle Girard, PhD", 
            "phone": "0033555431028"
        }, 
        "overall_official": {
            "affiliation": "CH Esquirol", 
            "last_name": "Dominique Malauzat, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France : Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The clinical improvement is defined as :\n30% decrease in the general painful state evaluated by VAS between T0 and T21 and response to the Patient's Global Impression of Change \u2265 6 at T21", 
            "measure": "Variation in the Visual Analogic Scale (VAS)score after fixe pressure application (160 kPa) between the first rTMS session (T0) and the last rTMS session (T21)in relation to clinical improvement", 
            "safety_issue": "No", 
            "time_frame": "21 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01992822"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Esquirol", 
            "investigator_full_name": "Dominique Malauzat", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "variation in the experimental pain feeling (VAS) between T0 and T21 in relation to treatment group", 
                "safety_issue": "No", 
                "time_frame": "21 days"
            }, 
            {
                "measure": "variation in experimental pain feeling between T0 and T210 (the end of rTMS maintenance sessions)", 
                "safety_issue": "No", 
                "time_frame": "210 days"
            }, 
            {
                "measure": "variation in Beck Depression Inventory scores between T0 and T21", 
                "safety_issue": "No", 
                "time_frame": "21 days"
            }, 
            {
                "measure": "variation in Fibromyalgia Impact Questionnaire score between T0 and T21", 
                "safety_issue": "No", 
                "time_frame": "21 days"
            }
        ], 
        "source": "Centre Hospitalier Esquirol", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Esquirol", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}